INVESTOR ALERT: Shareholder Class Action Lawsuit Filed Against BioAge Labs, Inc. (NASDAQ: BIOA); DiCello Levitt LLP Encourages Investors with Losses to Discuss Their Options with Counsel
10 janv. 2025 16h15 HE
|
DiCello Levitt LLP
SAN DIEGO, Jan. 10, 2025 (GLOBE NEWSWIRE) -- A class action lawsuit has been filed on behalf of all persons and entities who purchased BioAge Labs, Inc. (NASDAQ: BIOA) (“BioAge” or the “Company”)...
BioAge Labs Investors Who Have Lost Money Should Contact Block & Leviton to Find Out How They Might Recover Money Through The Firm’s Investigation
23 déc. 2024 08h24 HE
|
Block & Leviton LLP
Block & Leviton is investigating BioAge Labs after the company discontinued its STRIDES Phase 2 trial for azelaprag. Investors should contact the firm.
BioAge Labs, Inc. ALERT: Securities Fraud Investigation by Block & Leviton Could Allow Investors to Recover Losses
10 déc. 2024 10h02 HE
|
Block & Leviton LLP
Block & Leviton is investigating BioAge Labs, Inc. (Nasdaq: BIOA) for potential securities law violations. Investors should contact the firm to learn more.